Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis

NCT01758510 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis
Motor Neuron Disease
Neuromuscular Disease
Neurodegenerative Disease
Central Nervous System Disease

Interventions

GENETIC: HYNR-CS-Allo

Sponsor

Hanyang University Seoul Hospital

Collaborators

[object Object]